This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

Small studies link Ozempic and similar drugs to rare but serious eye conditions. However, experts say there's no need to ...

Trump directed a panel headed by HHS Secretary Robert F. Kennedy Jr. to assess “the prevalence of and threat” posed by SSRIs, ...

For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

Novo Nordisk has been looking to diversify its lineup in recent years, and is developing medicines in other fields. The ...

Swimsuit Illustrated Sports Issue model and Denise Austin's daughter, Katie Austin, explained why she will never take Ozempic.

Here are 5 of CFRA analysts' top growth stocks that have reported at least 15% annual revenue growth in the past three years.

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

The 200-acre Lilly Medicine Foundry is expected to add 400 full-time jobs for highly skilled workers, including engineers, ...